Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 19/20 | 0.72 |
| ▸ | THRA | P10827 | 18/20 | 0.72 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.53 |
| ▸ | AR | P10275 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4362345 | 0.89 | THRB (0.72) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4923097 | 0.89 | THRB (0.72) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4362409 | 0.87 | THRB (0.74) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4532725 | 0.87 | THRB (0.74) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4360360 | 0.86 | THRA (0.69) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4345721 | 0.84 | THRB (0.69) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4931391 | 0.81 | THRB (0.62) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4934044 | 0.81 | THRB (0.62) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4923163 | 0.81 | THRB (0.62) | THRBTHRAESR1NR3C1PGR | |
| SCHEMBL4353660 | 0.79 | THRB (0.69) | THRBTHRAESR1NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009080835-A1 | THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING | KARO BIO AB (SE) | 2009-07-02 | — | — | WO | disclosed |